复方苦参注射液联合XeLOX方案治疗结直肠癌肝转移临床观察(2)
 |
| 第1页 |
参见附件。
[3]Gao YH, Zhang X, An X, et al. Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer[J].Strahlenther Onkol,2014,190(2):158-164.
[4]Murata K, Okamura S, Okubo H, et al. Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer[J]. Gan To Kagaku Ryoho,2013,40(12):2020-2022.
[5]Hiraki S, Kuwahara T, Kaneko T,et al. A case of locally advanced rectal cancer successfully resected after preoperative chemotherapy[J]. Gan To Kagaku Ryoho,2013,40(12):1947-1949.
[6]Zhao Q, Li Y, Tan BB,et al. Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer[J]. Zhonghua Zhong Liu Za Zhi,2013,35(10):773-777.
[7]趙世福,赵玉玲,刘书峰.肝癌组织PTEN的表达及临床意义[J].中外医学研究,2011,23:6-8.
[8]陈超.16层螺旋CT在直肠癌N分期中的应用效果观察[J].中外医疗,2012,2(1):284.
[9]高亚丽,韩英民,侯建峰. 替吉奥联合伊立替康治疗晚期结直肠癌的临床疗效观察[J].中国医学创新，2013, (16) :17-19.
[10]唐滟,张兵,谢军. 同步放化疗治疗术后复发性直肠癌的近期疗效观察[J].中国医学创新, 2012, (05) :30-31.
[11]王丙炎,刘战丛,李贺鹏.结直肠癌根治术后复发转移的危险因素分析[J].中国医学创新, 2012, (11) :7-9.
[12]钟晓华,陈超,傅继勇,等.结直肠癌肝转移治疗效果评价及预后的影响因素分析[J].中国医学创新,2012, (35) :45-46.编辑/哈涛
您现在查看是摘要介绍页，详见PDF附件。